
Niva Bupa Health (NIVABUPA) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
13.7B
Net Income
-914.4M
-6.67%
EPS (Diluted)
₹-0.50
Balance Sheet Metrics
Total Assets
97.6B
Total Liabilities
52.7B
Shareholders Equity
44.9B
Debt to Equity
1.17
Cash Flow Metrics
Free Cash Flow
701.2M
Revenue & Profitability Trend
Niva Bupa Health Income Statement From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue | 56.9B | 41.2B | 28.0B | 18.4B |
Cost of Goods Sold | - | - | - | - |
Gross Profit | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | ||||
Research & Development | - | - | - | - |
Selling, General & Administrative | 2.3B | 1.8B | 3.8B | 3.1B |
Other Operating Expenses | -1.2B | 2.2B | -3.5B | -2.6B |
Total Operating Expenses | 1.1B | 4.0B | 353.9M | 551.7M |
Operating Income | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | ||||
Interest Income | 1.8B | 1.3B | 548.6M | 377.6M |
Interest Expense | 636.6M | 532.2M | 451.3M | 161.8M |
Other Non-Operating Income | -1.7M | 0 | -140.0K | -1.3M |
Pre-tax Income | 2.1B | 818.5M | 125.4M | -2.0B |
Income Tax | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | 2.1B | 818.5M | 125.4M | -2.0B |
Net Margin % | 3.8% | 2.0% | 0.4% | -10.7% |
Key Metrics | ||||
EBITDA | - | - | - | - |
EPS (Basic) | ₹1.22 | ₹0.45 | ₹0.07 | ₹-1.08 |
EPS (Diluted) | ₹1.20 | ₹0.45 | ₹0.07 | ₹-1.08 |
Basic Shares Outstanding | 1752900000 | 1827026398 | 1827026398 | 1827026398 |
Diluted Shares Outstanding | 1752900000 | 1827026398 | 1827026398 | 1827026398 |
Income Statement Trend
Niva Bupa Health Balance Sheet From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Assets | ||||
Current Assets | ||||
Cash & Equivalents | 2.2B | 1.4B | 1.0B | 588.1M |
Short-term Investments | 10.9B | 4.5B | 3.6B | 3.4B |
Accounts Receivable | - | - | - | - |
Inventory | - | - | - | - |
Other Current Assets | - | - | - | - |
Total Current Assets | - | - | - | - |
Non-Current Assets | ||||
Property, Plant & Equipment | 292.3M | 196.1M | 187.2M | 172.3M |
Goodwill | 309.6M | 343.4M | 267.8M | 251.3M |
Intangible Assets | 309.6M | 343.4M | 267.8M | 251.3M |
Long-term Investments | 0 | 0 | 0 | 0 |
Other Non-Current Assets | - | - | - | - |
Total Non-Current Assets | - | - | - | - |
Total Assets | 97.6B | 61.9B | - | - |
Liabilities | ||||
Current Liabilities | ||||
Accounts Payable | - | - | - | - |
Short-term Debt | 0 | - | - | - |
Current Portion of Long-term Debt | - | - | - | - |
Other Current Liabilities | - | - | - | - |
Total Current Liabilities | - | - | - | - |
Non-Current Liabilities | ||||
Long-term Debt | 2.5B | 2.5B | - | - |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - |
Total Liabilities | 52.7B | 22.8B | - | - |
Equity | ||||
Common Stock | 18.3B | 17.0B | 15.1B | 14.1B |
Retained Earnings | 7.2B | 9.3B | 0 | 0 |
Treasury Stock | - | - | - | - |
Other Equity | - | - | - | - |
Total Shareholders Equity | 44.9B | 39.1B | 20.9B | 17.8B |
Key Metrics | ||||
Total Debt | 2.5B | 2.5B | 0 | 0 |
Working Capital | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Niva Bupa Health Cash Flow Statement From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Operating Activities | ||||
Net Income | - | - | - | - |
Depreciation & Amortization | - | - | - | - |
Stock-Based Compensation | - | - | - | - |
Working Capital Changes | 0 | 0 | 0 | 0 |
Operating Cash Flow | - | - | - | - |
Investing Activities | ||||
Capital Expenditures | -408.6M | -328.3M | -377.9M | -287.9M |
Acquisitions | - | - | - | - |
Investment Purchases | -59.9B | -47.7B | -27.7B | -25.2B |
Investment Sales | 33.1B | 27.0B | 18.1B | 17.3B |
Investing Cash Flow | -23.5B | -18.8B | -8.3B | -7.2B |
Financing Activities | ||||
Share Repurchases | - | - | - | - |
Dividends Paid | - | - | - | - |
Debt Issuance | 0 | 0 | 0 | 2.5B |
Debt Repayment | 0 | 0 | 0 | 0 |
Financing Cash Flow | 8.0B | 11.4B | 3.1B | 3.7B |
Free Cash Flow | 16.1B | 7.8B | 5.5B | 3.1B |
Net Change in Cash | -15.5B | -7.4B | -5.2B | -3.5B |
Cash Flow Trend
Niva Bupa Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
110.79
Forward P/E
53.40
Price to Book
4.67
Price to Sales
2.39
Profitability Ratios
Profit Margin
2.01%
Operating Margin
-6.66%
Return on Equity
4.75%
Return on Assets
2.19%
Financial Health
Debt to Equity
7.71
Per Share Data
EPS (TTM)
₹0.76
Book Value per Share
₹18.02
Revenue per Share
₹36.44
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
nivabupa | 155.4B | 110.79 | 4.67 | 4.75% | 2.01% | 7.71 |
Life Insurance | 5.7T | 11.60 | 4.99 | 37.90% | 6.20% | 0.00 |
SBI Life Insurance | 1.9T | 74.87 | 10.42 | 14.90% | 2.05% | 0.00 |
Religare Enterprises | 84.4B | 72.08 | 3.35 | 3.64% | 1.56% | 6.79 |
HDFC Life Insurance | 1.7T | 91.24 | 10.05 | 11.61% | 1.89% | 17.31 |
ICICI Prudential | 920.3B | 73.07 | 7.34 | 10.59% | 1.78% | 20.73 |
Financial data is updated regularly. All figures are in the company's reporting currency.